Originally published on Fri May 10, 2013 9:10 am
Cervical cancer takes its greatest toll in the countries whose economies and health systems are poorest.
Women in those places are less likely than those in rich countries to get regular Pap tests to detect the cancers when it can be treated effectively.
Of the 275,000 women who die of cervical cancer each year, more than 85 percent, or at least 234,000, are in low-income countries.
But a vaccine that can prevent cervical cancer could go a long way toward lowering the risk in those less developed countries. Problem is, the shots are pretty expensive.
Originally published on Mon May 6, 2013 11:18 am
The men and women who often treat prostate cancer are now recommending that the blood test commonly used to screen for it should be given a lot less often.
The American Urological Association released new guidelines that, if they're heeded, would dramatically reduce the ranks of men who would be candidates for PSA testing.
Where preventive health care is concerned, a colonoscopy is one of the pricier screening tests, with a cost that often exceeds $1,000.
But under the health care overhaul, most health insurance plans have to cover the test for colorectal cancer without billing patients a dime, even if a polyp is found and removed.
Yet the way your doctor categorizes the test can make all the difference.